An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer-Reference-Cited by-同舟云学术

An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer

Published:2019-10 Issue: Volume:118 Page:109169
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhang Jue,Qu Zhipeng,Yao Hong,Sun Lingling,Harata-Lee Yuka,Cui Jian,Aung Thazin Nwe,Liu Xiaomin,You Rongli,Wang Wei,Hai Lina,Adelson David L.,Lin Lizhu

Funder

Special International Cooperation Project of Traditional Chinese Medicine

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference53 articles.

1. Lung cancer surgery: an up to date;Baltayiannis;J. Thorac. Dis.,2013

2. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers;Shigematsu;Int. J. Cancer,2006

3. Targeted therapies: afatinib--new therapy option for EGFR-mutant lung cancer;Yu;Nat. Rev. Clin. Oncol.,2013

4. Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002);Inoue;Ann. Oncol.,2013

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Protective Effect of Compound Kushen Injection Against Radiation- induced Pneumonitis in Mice;2024-01-30

2. Mechanism of Sophorae Flavescentis Radix (Kushen) in treating NSCLC: Insights from miRNA-mRNA network analysis;Journal of Ethnopharmacology;2024-01

3. Tumor microenvironment diversity and plasticity in cancer multidrug resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022;Frontiers in Pharmacology;2023-07-04

5. Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-03-03